Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.

M Sakaguchi, M W Webb, K C Agrawal

    Journal of Medicinal Chemistry
    |November 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Study of Clinical, Bacteriological & Histopathological Correlation in Leprosy Cases attending a Government Medical College in Western Odisha: Some Observations.

    Indian journal of leprosy·2018
    Same author

    Radioprotection in mice following oral delivery of amifostine nanoparticles.

    International journal of radiation biology·2005
    Same author

    Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases.

    AIDS research and human retroviruses·2002
    Same author

    Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
    Same author

    In vivo gene expression profile analysis of metallothionein in renal cell carcinoma.

    Cancer letters·2000
    Same author

    Longer-term diabetic patients have a more frequent incidence of nosocomial infections after elective gastrectomy.

    Anesthesia and analgesia·2000

    New 2-nitroimidazole nucleoside analogues show promise as radiosensitizers. Thioglucose and sialic acid derivatives effectively enhanced cancer cell radiosensitivity, potentially reducing neurotoxicity.

    Area of Science:

    • Medicinal Chemistry
    • Radiochemistry
    • Cancer Biology

    Background:

    • Radiosensitizers enhance the efficacy of radiation therapy in cancer treatment.
    • 2-nitroimidazole derivatives are explored for their radiosensitizing properties.
    • Reducing neurotoxicity and increasing therapeutic efficacy are key goals in radiosensitizer development.

    Purpose of the Study:

    • To synthesize novel 2-nitroimidazole nucleoside analogues as potential radiosensitizers.
    • To evaluate the cytotoxicity and radiosensitizing activity of these analogues in vitro.
    • To identify analogues with improved therapeutic potential by reducing neurotoxicity.

    Main Methods:

    • Synthesis of 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl and glucothiopyranosyl analogues of 2-nitroimidazole via condensation reactions.

    Related Experiment Videos

  • Deacetylation of synthesized esters using sodium methoxide.
  • Condensation of a trimethylsilyl derivative of 2-nitroimidazole with a sialic acid derivative.
  • In vitro testing of synthesized agents for cytotoxicity and radiosensitization against Chinese hamster (V-79) cells under oxic and hypoxic conditions.

    • Main Results:

    • The synthesized 2-nitroimidazole nucleoside analogues were evaluated for their biological activity.
    • Both thioglucose and sialic acid analogues demonstrated significant radiosensitizing effects.
    • Cytotoxicity and radiosensitization were assessed under both oxygen-rich (oxic) and low-oxygen (hypoxic) conditions.

    Conclusions:

    • Novel 2-nitroimidazole nucleoside analogues, specifically thioglucose and sialic acid derivatives, are effective radiosensitizers.
    • These compounds hold potential for improving radiation therapy outcomes by enhancing tumor cell killing.
    • Further research may focus on optimizing these analogues to minimize neurotoxicity and maximize therapeutic benefit.